AMPLIFY™ Technology Enhances Prenatal Screening for 22q11.2 Microdeletion
Myriad Genetics
APRIL 15, 2024
For any parent, learning after delivery that their baby may have a serious chromosomal condition can be heartbreaking and scary. Unfortunately, some conditions are very difficult to detect during pregnancy without invasive diagnostic testing, which may not be indicated for a young, healthy pregnant person with a typically progressing pregnancy. Such is the case with the 22q11.2 microdeletion syndrome, a relatively common and potentially serious chromosomal abnormality. 22q, as it is colloquia
52 
Let's personalize your content